DRKS00028707RecruitingNot Applicable
Evaluation of Transplant-reactive T cells for the Prediction or Diagnosis of Transplant Rejection in Kidney Transplant Recipients (TreaT-Assay) - TreaT-Assay
Charité Campus Virchow-Klinikum0 sites185 target enrollmentStarted: April 27, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 185
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 110 Years (—)
- Sex
- All
Inclusion Criteria
- •Condition after kidney transplant or non-kidney transplant control
- •- Deterioration of transplant function and indication for renal transplant biopsy
- •- Signed informed consent form
- •- Age >18 years
- •- Existing health insurance
Exclusion Criteria
- •- Age under 18 years
- •- Lack of capacity to give consent
- •- Lack of written informed consent
- •- viral infections such as hepatitis B, hepatitis C or/and HIV
Investigators
Similar Trials
Completed
Not Applicable
A pilot study to characterize T cell responses in young children after influenza infectio10047438influenzaNL-OMON33577niversitair Medisch Centrum Utrecht125
Completed
Not Applicable
An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, IndiaCTRI/2021/03/032028Dr D Y Patil Vidyapeeth Pune137
Not yet recruiting
Not Applicable
Adoptive Transfer of T cell Receptor-engineered T cells to treat hepAtocellular Carcinoma recurrence after liver Transplantation: a preclinical feasibility studyLiver CancerPrimary Liver Cell Carcinoma100196541000381610019815NL-OMON47991Erasmus MC, Universitair Medisch Centrum Rotterdam35
Recruiting
Not Applicable
Investigation of drug specific cytotoxic T cell in severe cutaneous adverse drug reactioJPRN-UMIN000009708Yokohama City University Graduate School of Medicine10
Recruiting
Phase 1
Immune cell therapy for pediatric patients with brain tumor.Malignant brain tumorJPRN-jRCTc030200051Kondo Akihide3
